These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16449712)

  • 1. Schizophrenia, weight gain and atypical antipsychotics.
    Brown S
    Br J Psychiatry; 2006 Feb; 188():191-2. PubMed ID: 16449712
    [No Abstract]   [Full Text] [Related]  

  • 2. Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia.
    Marteene W; Winckel K; Hollingworth S; Kisely S; Gallagher E; Hahn M; Ebdrup BH; Firth J; Siskind D
    Expert Opin Drug Saf; 2019 Dec; 18(12):1149-1160. PubMed ID: 31564170
    [No Abstract]   [Full Text] [Related]  

  • 3. Weight change and atypical antipsychotic treatment in patients with schizophrenia.
    Jones B; Basson BR; Walker DJ; Crawford AM; Kinon BJ
    J Clin Psychiatry; 2001; 62 Suppl 2():41-4. PubMed ID: 11232752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment with atypical antipsychotics and risk of weight gain.
    Stip E; Anselmo K; Wolfe M; Lessard C; Landry P
    Drug Saf; 2006; 29(6):550-2; author reply 552. PubMed ID: 16752937
    [No Abstract]   [Full Text] [Related]  

  • 5. Interventions to reduce weight gain in schizophrenia.
    Faulkner G; Cohn T; Remington G
    Schizophr Bull; 2007 May; 33(3):654-6. PubMed ID: 17449900
    [No Abstract]   [Full Text] [Related]  

  • 6. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive α-lipoic acid reduces weight gain compared with placebo at 12 weeks in schizophrenic patients treated with atypical antipsychotics: a double-blind randomized placebo-controlled study.
    Kim NW; Song YM; Kim E; Cho HS; Cheon KA; Kim SJ; Park JY
    Int Clin Psychopharmacol; 2016 Sep; 31(5):265-74. PubMed ID: 27276401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subjective Versus Objective Weight Gain During Acute Treatment With Second-Generation Antipsychotics in Schizophrenia and Bipolar Disorder.
    Gao K; Fang F; Wang Z; Calabrese JR
    J Clin Psychopharmacol; 2016 Dec; 36(6):637-642. PubMed ID: 27753728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differing tolerability profiles among atypical antipsychotics.
    Hellewell JS; Haddad PM
    Am J Psychiatry; 2001 Mar; 158(3):501-2. PubMed ID: 11230007
    [No Abstract]   [Full Text] [Related]  

  • 10. Schizophrenia, obesity, and antipsychotic medications: what can we do?
    Citrome L; Vreeland B
    Postgrad Med; 2008 Jul; 120(2):18-33. PubMed ID: 18654065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
    Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL
    J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic-associated weight gain and clinical outcome parameters.
    Blin O; Micallef J
    J Clin Psychiatry; 2001; 62 Suppl 7():11-21. PubMed ID: 11346191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical implications of weight gain in schizophrenia.
    Kurzthaler I; Fleischhacker WW
    J Clin Psychiatry; 2001; 62 Suppl 7():32-7. PubMed ID: 11346194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A program for managing weight gain associated with atypical antipsychotics.
    Vreeland B; Minsky S; Menza M; Rigassio Radler D; Roemheld-Hamm B; Stern R
    Psychiatr Serv; 2003 Aug; 54(8):1155-7. PubMed ID: 12883145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schizophrenia, antipsychotics and metabolic disease.
    Reynolds GP
    J Psychopharmacol; 2007 Jun; 21(4):355-6. PubMed ID: 17656424
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of weight gain in patients with schizophrenia.
    Aquila R
    J Clin Psychiatry; 2002; 63 Suppl 4():33-6. PubMed ID: 11913674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin for treatment of antipsychotic-induced weight gain in a South Asian population with schizophrenia or schizoaffective disorder: A double blind, randomized, placebo controlled study.
    de Silva VA; Dayabandara M; Wijesundara H; Henegama T; Gunewardena H; Suraweera C; Hanwella R
    J Psychopharmacol; 2015 Dec; 29(12):1255-61. PubMed ID: 26510448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight gain and first-generation antipsychotics: experience from a developing country.
    Yoon CK
    J Clin Psychopharmacol; 2008 Oct; 28(5):574-6. PubMed ID: 18794660
    [No Abstract]   [Full Text] [Related]  

  • 19. Antipsychotic drugs: the weight problem.
    Harv Ment Health Lett; 2000 Dec; 17(6):6-8. PubMed ID: 11114878
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of atypical antipsychotics in children: balancing safety and effectiveness.
    Kohlstadt I; Vitiello B
    Am Fam Physician; 2010 Mar; 81(5):585. PubMed ID: 20187594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.